Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 296 entries
View as:

SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00698828 Org: User:
Start: 05/15/08 End: 10/08/09 Due: 10/08/10

Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT00781391 Org: User:
Start: 11/30/08 End: 05/31/13 Due: 05/31/14

Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01290471 Org: User:
Start: 01/31/11 End: 01/31/13 Due: 01/31/14

WelChol® and Insulin in Treating Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00151749 Org: User:
Start: 06/30/04 End: 12/31/05 Due: 12/31/06

The Effect of CS-3150 Exposure on Corrected QT (QTc) Interval Duration in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04019652 Org: User:
Start: 11/19/15 End: 12/23/15 Due: 12/23/16

Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00623363 Org: User:
Start: 07/13/07 End: 07/17/08 Due: 07/17/09

Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00967616 Org: User:
Start: 09/30/09 End: 04/30/13 Due: 04/30/14

A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin

Phase: N/A Priority: Normal
NCT ID: NCT00185094 Org: User:
Start: 02/29/04 End: 07/31/05 Due: 07/31/06

A Study of DS-8201a in Metastatic Breast Cancer Previously Treated With Trastuzumab Emtansine (T-DM1)

Phase: N/A Priority: Normal
NCT ID: NCT03248492 Org: User:
Start: 08/25/17 End: 05/06/24 Due: 05/06/25

Exatecan Mesylate in Treating Patients With Ewing's Sarcoma, Primitive Neuroectodermal Tumor, or Desmoplastic Small Round Cell Tumor

Phase: N/A Priority: Normal
NCT ID: NCT00055952 Org: User:
Start: 01/31/03 End: 04/30/06 Due: 04/30/07

Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)

Phase: N/A Priority: Normal
NCT ID: NCT04704934 Org: User:
Start: 05/21/21 End: 02/01/26 Due: 02/01/27

Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Study

Phase: N/A Priority: Normal
NCT ID: NCT02303431 Org: User:
Start: 11/05/14 End: 09/16/21 Due: 09/16/22

Chemotherapy in Treating Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00004045 Org: User:
Start: 06/30/99 End: 08/31/01 Due: 08/31/02

Effects of CS-8080 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00613431 Org: User:
Start: 01/31/08 End: - Due: -

Randomized, Double-blind, Active-controlled, Study of Rivoglitazone in Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00571519 Org: User:
Start: 11/14/07 End: 05/23/08 Due: 05/23/09

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

Phase: N/A Priority: Normal
NCT ID: NCT06824168 Org: User:
Start: 06/27/25 End: 07/14/32 Due: 07/14/33

Patritumab With Cetuximab and a Platinum Containing Therapy for Patients With Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02350712 Org: User:
Start: 12/31/14 End: 06/30/16 Due: 06/30/17

CS1008- in Combination With Sorafenib Compared to Sorafenib Alone in Subjects With Advanced Liver Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01033240 Org: User:
Start: 07/09/10 End: 09/09/13 Due: 09/09/14

Chemotherapy in Treating Patients With Recurrent, Metastatic, or Unresectable Ovarian, Fallopian Tube, or Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00004060 Org: User:
Start: 07/31/99 End: 09/30/00 Due: 09/30/01

Edoxaban Treatment in Routine Clinical Practice for Patients With Non Valvular Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT02944019 Org: User:
Start: 08/31/15 End: 04/13/22 Due: 04/13/23

Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT00259038 Org: User:
Start: 01/31/04 End: 02/28/06 Due: 02/28/07

Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffeine, Midazolam, and Digoxin in Cancer Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01517399 Org: User:
Start: 12/31/11 End: 09/30/13 Due: 09/30/14

Medical Access Program for Datopotamab Deruxtecan in EGFRm NSCLC Patients

Phase: N/A Priority: Normal
NCT ID: NCT06279728 Org: User:
Start: - End: - Due: -

Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01525602 Org: User:
Start: 05/31/12 End: 02/28/18 Due: 02/28/19

A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Hypertensive Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02345044 Org: User:
Start: 01/31/15 End: 10/31/15 Due: 10/31/16